FindTrial
Sign In

Study for Acupoint Catgut Embedding Compared with Sustained-release Bupropion for Treating Tobacco Dependence

Study for Acupoint Catgut Embedding Compared with Sustained-release Bupropion for Treating Tobacco Dependence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020676
Enrollment
Unknown
Registered
2019-01-12
Start date
2016-08-18
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco dependence

Interventions

One:Acupoint Catgut Embedding
Two:Sustained-release bupropion

Sponsors

Seventh People's Hospital of Nanning
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Smoking for more than one year; (2) Smoking= 10 cigarettes per day; (3) Aged 18-70 years; (4) Fagerstrom Test for Nicotine Dependence score = 4; (5) Minnesota Tobacco Withdrawal Symptoms Scale (MNWS) score =1; (6) Patients are willing to accept smoking cessation treatment, and all patients sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Take other related drugs by oneself to affect the judgement of curative effect; (2) cannot insist on the treatment of self-withdrawal; (3) merge with other serious primary diseases; with severe liver and kidney dysfunction; (4) have a history of severe allergy or contraindication of using amphetazone hydrochloride sustained-release tablets.

Design outcomes

Primary

MeasureTime frame
Fagerstrom Test for Nicotine Dependence (FTND);the continuous abstinence rates;The therapeutic effects;Treatment adherence rate;Adverse reaction rate;Minnesota Nicotine Withdrawal Scale;—

Countries

China

Contacts

Public ContactHe Wei

Seventh people's Hospital of Nanning

douglas800331@gmail.com+86 13977125331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026